4//SEC Filing
Hayes Melvin H. III 4
Accession 0000899243-22-028370
CIK 0001680581other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:15 PM ET
Size
5.6 KB
Accession
0000899243-22-028370
Insider Transaction Report
Form 4
Hayes Melvin H. III
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2022-08-09+137,000→ 137,000 totalExercise: $7.40Exp: 2032-08-08→ Common Stock (137,000 underlying)
Footnotes (1)
- [F1]This option was granted on August 9, 2022 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of August 9, 2022. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001937148
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 4:15 PM ET
- Size
- 5.6 KB